We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

What can we learn from the NMC Health collapse?

The collapse of NMC Health has shown us that even a shining FTSE 100 champion can be rotten underneath. We can learn a few things from the scandal.

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

I’ve seen plenty of company collapses during my years as a private investor. But it’s rare it happens to one that’s made it as far as the FTSE 100. That’s what’s happened to NMC Health (LSE: NMC), and there are lessons to be learned.

At its peak in 2018, NMC Health stock was trading at more than £40 per share. Now on Monday, the end of NMC as a listed company has come, after it requested the cancellation of its shares on the London Stock Exchange.

Should you buy Rolls Royce shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

On 13 April, NMC Health announced it had called in the administrators, under pressure from Abu Dhabi Commercial Bank, to which it owed $1bn. That was a month after trading in the shares had been suspended, at a price of 938p. What are they worth now? I reckon almost certainly zero.

NMC Health in administration

My Motley Fool colleague Edward Sheldon has explained how a company entering administration is bad news for shareholders. The company’s creditors and bondholders are ahead in the queue. And if there’s anything left of its assets once its debts are dealt with, only then might shareholders be left with anything.

I seriously doubt there’ll be anything left, as the scale of NMC Health’s debts is truly shocking. It includes previously undisclosed debt of $4bn, for a total debt pile of more than $6.5bn.

Lesson number one

And here’s one lesson for investors. We might wonder how this can happen to a company regulated by the LSE with a FTSE 100 listing. And we might wonder if LSE auditing regulations are too lax. But the thing is, a company’s auditors are working on the company’s behalf. And unless they find anything glaring, they have to take a lot of what the company says in good faith.

The auditors aren’t being paid by the company to perform an in-depth investigation to look for wrongdoings. So don’t assume that just because a company is in the FTSE 100, its accounts must be squeaky clean.

Shorting NMC Health

It’s different for investigative investors such as Muddy Waters, which essentially pulled the plug on NMC Health in December. Back then, Muddy Waters said it believed NMC had “manipulated its balance sheet to understate debt,” having taken a short position against the firm.

And that leads me to lesson number two. A firm like Muddy Waters has to have a pretty tight case to make such potentially devastating claims. And it has a reputation for first-class investigative skills. In my view, it’s going to be very rare Muddy Waters will get something like this wrong. So the lesson I take is — if Muddy Waters says a company’s bad, run for the hills.

The signs were there

Now we know the scale of the debt understatement, Muddy Waters has been well and truly vindicated. Shareholders who heeded December’s report and sold out saved themselves from total wipeout. And, as it happens, NMC Health chairman BR Shetty and vice-chairman Khalifa Al Muhairi dumped a load of shares in January and February.

So, final lesson. When a company is up to its neck in trouble and key insiders are selling, well, I think you know the rest.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended NMC Health. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

CMC Markets: a FTSE dividend star worth considering for an ISA or SIPP?

This FTSE dividend stock doesn’t get a lot of attention. But things are starting to change as it’s posting brilliant…

Read more »

British coins and bank notes scattered on a surface
Investing Articles

Income investors love insurance stocks. Here’s my top pick from the FTSE 100

High dividend yields often make insurance stocks attractive for passive income investors. But which is Stephen Wright’s top choice?

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

See what £10,000 invested in dismal Diageo shares just 1 week ago is worth today

Diageo shares are all hangover and no fizz, says Harvey Jones. How long must investors wait before the FTSE 100…

Read more »

Rear view image depicting a senior man in his 70s sitting on a bench leading down to the iconic Seven Sisters cliffs on the coastline of East Sussex, UK. The man is wearing casual clothing - blue denim jeans, a red checked shirt, navy blue gilet. The man is having a rest from hiking and his hiking pole is leaning up against the bench.
Investing Articles

Up 1,146%! 7 things I’ve learned from the stunning Rolls-Royce share price comeback 

Harvey Jones has made a fair bit of money out of the booming Rolls-Royce share price, but he's also learned…

Read more »

Golden Retirees Heading to Beach
Investing Articles

4 steps to building a £38,456 retirement income with ISA shares

Investing £300 a month could deliver a life-changing cash stream in retirement with high-yield income shares. Royston Wild explains how.

Read more »

Content white businesswoman being congratulated by colleagues at her retirement party
Investing Articles

How investing in a Cash ISA could cost you a comfortable retirement

Cash ISAs are celebrated for the brilliant tax benefits they provide. But could focusing on them cost savers the chance…

Read more »

Young black woman in a wheelchair working online from home
Investing Articles

How much could Barclays shares pay in dividends by 2028?

Barclays is one of the FTSE 100's most popular dividend shares. How much could they provide over the next three…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

With a 6% yield and a P/E of just 7.4, is this share a screaming buy for a second income?

Mark Hartley looks at the second income potential of a popular UK dividend stock that still looks undervalued despite compelling…

Read more »